Cargando…
Discovery of Novel Orally Active Anti-Inflammatory N-Phenylpyrazolyl-N-Glycinyl-Hydrazone Derivatives That Inhibit TNF-α Production
Herein, we describe the synthesis and pharmacological evaluation of novel N-phenylpyrazolyl-N-glycinyl-hydrazone derivatives that were designed as novel prototypes of p38 mitogen-activated protein kinase (MAPK) inhibitors. All of the novel synthesized compounds described in this study were evaluated...
Autores principales: | Lacerda, Renata B., da Silva, Leandro L., de Lima, Cleverton K. F., Miguez, Eduardo, Miranda, Ana Luisa P., Laufer, Stefan A., Barreiro, Eliezer J., Fraga, Carlos A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466213/ https://www.ncbi.nlm.nih.gov/pubmed/23056531 http://dx.doi.org/10.1371/journal.pone.0046925 |
Ejemplares similares
-
Novel Potent Imidazo[1,2-a]pyridine-N-Glycinyl-Hydrazone Inhibitors of TNF-α Production: In Vitro and In Vivo Studies
por: Lacerda, Renata B., et al.
Publicado: (2014) -
LASSBio-1135: A Dual TRPV1 Antagonist and Anti-TNF-Alpha Compound Orally Effective in Models of Inflammatory and Neuropathic Pain
por: Lima, Cleverton K. F., et al.
Publicado: (2014) -
Antimycobacterial Activities of N-Substituted-Glycinyl 1H-1,2,3-Triazolyl Oxazolidinones and Analytical Method Development and Validation for a Representative Compound
por: Al-Tannak, Naser F., et al.
Publicado: (2017) -
In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis
por: Silva, Dahara Keyse Carvalho, et al.
Publicado: (2020) -
Characterization of Amide Bond Conformers for a Novel Heterocyclic Template of N-acylhydrazone Derivatives
por: Lopes, Alexandra Basilio, et al.
Publicado: (2013)